---
$id: https://graph.org.ai/products/commodity/51271608
$type: Product
source: UNSPSC
code: "51271608"
title: "Clibucaine"
class: "51271600"
classTitle: "Anaesthetic amides"
family: "51270000"
familyTitle: "Anaesthetic drugs and related adjuncts and analeptics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Clibucaine

**UNSPSC Code**: 51271608
**Class**: [Anaesthetic amides](Anaesthetic amides.mdx)
**Family**: [Anaesthetic drugs and related adjuncts and analeptics](../Anaesthetic drugs and related adjuncts and analeptics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anesthetic agent with the molecular formula C15H20Cl2N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NB2ZOX88RR, chemically known as 2,4-dichloro-beta-piperidinobutyranilide but generally known as clibucaine, which bears US NIH Compound Identifier 65613. European Medicines Agency schedules Clibucaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06657MIG. The term CLIBUCAINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). CLIBUCAINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clibucaine under HS 29333999 and SITC 51574. As of Q4 2014, CLIBUCAINE remains the US FDA Preferred Term for this commodity. Clibucaine bears US NLM identifiers UMLS ID C2699344 and NCI Concept Code C77321. SMILES: CLC1C(NC(=O)CC(N2CCCCC2)C)CCC(CL)C1.

